StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$48.22+0.22 (+0.46%)

Close on Nov 17, 2026Market cap $2.28BP/E 13.5Yield –

Prestige Consumer Healthcare EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Prestige Consumer Healthcare's EV/EBITDA was 12.6× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 7.7× to 560.2×, with a median of 12.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.6×+4.4
2025Dec 31, 20258.2×−5.6
2024Dec 31, 202413.8×−380.1
2023Dec 29, 2023393.9×+381.3
2022Dec 30, 202212.6×−0.9
2021Dec 31, 202113.5×+3.6
2020Dec 31, 20209.9×−30.5
2019Dec 31, 201940.4×+25.6
2018Dec 31, 201814.7×+0.3
2017Dec 29, 201714.4×−3.4
2016Dec 30, 201617.9×+2.6
2015Dec 31, 201515.3×−3.2
2014Dec 31, 201418.5×+5.4
2013Dec 31, 201313.2×−0.3
2012Dec 31, 201213.5×+3.3
2011Dec 30, 201110.3×+4.0
2010Dec 31, 20106.2×–

More Prestige Consumer Healthcare figures

See a number that looks wrong?